Adolescent ; Adult ; China ; epidemiology ; Emergency Service, Hospital ; Female ; Hand Injuries ; epidemiology ; Humans ; Male ; Surveys and Questionnaires

Cause of Death ; Humans ; Life Expectancy ; Mathematics ; Quality of Life ; Value of Life

Acupuncture Therapy ; Facial Paralysis ; therapy ; Humans ; Male

Acupuncture Points ; Acupuncture Therapy ; Female ; Glossopharyngeal Nerve Diseases ; therapy ; Humans ; Middle Aged ; Treatment Outcome

Effect of opsonized zpoosan on polymorphonuclear leukocyte (PMN)were studied by chemilundnescence (CL)and hydrogen peroxide (H2O2)assays. Results showed that different concentrations of Physalin B(PhB) presented a dose-dependent inhibitive effect on CL and H2O2 production of activated PMN. It suggested that the anti-inflammatory action of PhB may be related to the inhibition of production and release of oxygen free radical by PMN.

China ; Data Collection ; Safety ; Wounds and Injuries ; prevention & control

Catheter Ablation ; Humans ; Hypertension ; physiopathology ; surgery ; Kidney ; innervation ; Sympathetic Nervous System ; physiopathology

Objective To observe the effect of immunity condition and clinical manifestations of children with recurrent oral-ulcer(ROU)treated with aciclovir(ACV) and a-polyresistin.Methods Forty-eight patients with ROU were randomly divided into whole treated group(25 cases)and partial treatment group(23 cases).The changes of their peripheral blood lymphocyte subgroups,before and after treatment,were measured and contrasted to analyze the relationship with curative effect.Results The ratios of CD3,CD4,and CD4/CD8,after the treatment,increased obviously,while CD8 lowered obviously in treatment group(P0.05).The total clinical efficacy rate was 47.82%,moreover the patients were recurrent after 1 year.Conclusions ACV and a-polyresistin,through antivirus and regulating the immunity function get the 96% total clinical efficacy rate,and that controle the recurrent rate.It is superior to the traditional method.

OBJECTIVE:To provide reference for rational use of antibiotics in patients with AECOPD. METHODS:The patho-gen distribution and antibiotics use of AECOPD patients was analyzed in respiratory department of our hospital during 2014-2015. The infection site,pathogen distribution and antibiotics use(including medication purpose,drug name,usage,dosage,medication duration,route of administration,drug combination),infection and compliance were investigated and analyzed statistically. RE-SULTS:Among 967 AECOPD patients,there were 619 cases of positive sputum culture(64.01%). A total of 774 strains were iso-lated,including 542 strains of Gram-negative bacterial (70.03%) and 232 strains of Gram-positive bacterial (29.97%);most of them were Pseudomonas aeruginosa(207 strains,26.72%). 765 patients were treated with antibiotics,and utilization ratio of an-tibiotics was 79.11%. 276 cases were treated with one kinds of antibiotics (36.08%),435 treated with 2 kinds of antibiotics (56.86%)and 54 treated with 3 kinds of antibiotics and above(7.06%). Top 3 drugs in the list of frequency were Levofloxacin injection(455 cases/times,47.05%),Moxifloxacin injection(241 cases/times,24.92%)and Cefmetazole for injection(192 cas-es/times,19.86%). Top 3 drug combination regimen were Cefmetazole for injection+Levofloxacin injection (107 cases/times, 21.88%),Cefoxitin for injection+Levofloxacin injection(96 cases/times,19.63%)and Moxalactam for injection+Levofloxacin in-jection(65 cases/times,13.29%). CONCLUSIONS:Anti-infective therapy regimen of AECOPD patients should be formulated ac-cording to relevant guideline,and pathogenic factors of infection are analyzed. Great importance should be attached to reasonable, scientific,safe and standard use of antibiotics,etiological examination;pathogenic bacteria culture and drug sensitivity test should be conducted as soon as possible. So as to obtain better therapeutic efficacy and reduce the generation of drug-resistant strain.

Background and purpose:P38 mitogen-activated protein kinase (P38MAPK) signal transduction pathway is involved in occurrence, development and transfer process in a wide variety of tumors. Urokinase-type plasminogen activator (uPA) plays an important role in tumor invasion and metastasis. This study aimed to explore the clinical signiifcance of the P38MAPK signaling pathway and the expression of uPA in ovarian cancer.Methods:The expressions of uPA, P38MAPK, ERK and AKT were detected in 49 cases of cervical adenocarcinoma by immunohistochemistry. The expressions of uPA and P38MAPK were detected by Western blot in ovarian cancer cell lines HO8910, HO-8910PM, SKOV3 and CAOV3. The changes of uPA and P38MAPK were detected by SB203580, a speciifc inhibitor of P38MAPK signal transduction pathway.Results:The result of immunohistochemical method showed that positive expression rates for uPA, P38MAPK, ERK and AKT were 61.22%, 57.14%, 53.06% and 55.10%, respectively. The expression of the uPA was positively correlated with the P38MAPK (r=0.865,P=0.001), and related with clinicopathologic stage, differentiated degree, lymph node metastasis, but not related with age and histologic type (P>0.05). The expressions of AKT and ERK were related with the lymph node metastasis and greater omentum metastasis(P<0.05), but not related with age and histologic type (P>0.05). The expression of uPA in HO-8910PM was higher than that in ovarian cancer cell lines HO8910, SKOV3 and CAOV3, and the expression of uPA reduced when the P38MAPK signal transduction pathway was cut off by the SB203580. The expressions of P38MAPK and uPA were negatively correlated with the prognosis of ovarian cancer (Log-rank=3.897 and 11.044,P=0.048 and 0.001). Conclusion:The P38MAPK signal transduction pathway was activated in ovarian cancer. The activated P38MAPK signal transduction pathway can raise the expression of uPA, which may contribute to the development of ovarian cancer. The result indicates that the P38MAPK signal transduction pathway and uPA might play an important role in the invasion and metastasis of ovarian cancer. P38MAPK and uPA might be useful markers for evaluating prognosis of ovarian cancer.